Terms: = Colorectal cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Clinical Outcome
6 results:
1. Blocking histone methyltransferase SETDB1 inhibits tumorigenesis and enhances cetuximab sensitivity in colorectal cancer.
Hou Z; Sun L; Xu F; Hu F; Lan J; Song D; Feng Y; Wang J; Luo X; Hu J; Wang G
Cancer Lett; 2020 Sep; 487():63-73. PubMed ID: 32473242
[TBL] [Abstract] [Full Text] [Related]
2. Fibroblast Growth Factor Receptor 1 (fgfr1) Amplification Detected by Droplet Digital Polymerase Chain Reaction (ddPCR) Is a Prognostic Factor in colorectal cancers.
Bae JM; Wen X; Kim TS; Kwak Y; Cho NY; Lee HS; Kang GH
Cancer Res Treat; 2020 Jan; 52(1):74-84. PubMed ID: 31096734
[TBL] [Abstract] [Full Text] [Related]
3. The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer.
Tamagawa H; Oshima T; Shiozawa M; Morinaga S; Nakamura Y; Yoshihara M; Sakuma Y; Kameda Y; Akaike M; Masuda M; Imada T; Miyagi Y
Oncol Rep; 2012 Mar; 27(3):637-42. PubMed ID: 22076537
[TBL] [Abstract] [Full Text] [Related]
4. An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients.
Crea F; Fornaro L; Paolicchi E; Masi G; Frumento P; Loupakis F; Salvatore L; Cremolini C; Schirripa M; Graziano F; Ronzoni M; Ricci V; Farrar WL; Falcone A; Danesi R
Ann Oncol; 2012 May; 23(5):1207-1213. PubMed ID: 21926398
[TBL] [Abstract] [Full Text] [Related]
5. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients.
Bahnassy AA; Zekri AR; El-Houssini S; El-Shehaby AM; Mahmoud MR; Abdallah S; El-Serafi M
BMC Gastroenterol; 2004 Sep; 4():22. PubMed ID: 15385053
[TBL] [Abstract] [Full Text] [Related]
6. Economic evaluation in gastrointestinal disease.
Jönsson B; Karlsson G
Scand J Gastroenterol Suppl; 1996; 220():44-51. PubMed ID: 8898435
[TBL] [Abstract] [Full Text] [Related]
